{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T23:38:44Z","timestamp":1720481924752},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6,1]]},"DOI":"10.2146\/ajhp160714","type":"journal-article","created":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T10:40:11Z","timestamp":1495708811000},"page":"786-793","source":"Crossref","is-referenced-by-count":6,"title":["Coenzyme Q10 supplementation in the management of statin-associated myalgia"],"prefix":"10.1093","volume":"74","author":[{"given":"Jason T.","family":"Tan","sequence":"first","affiliation":[{"name":"Faculty of Pharmaceutical Sciences University of British Columbia Vancouver, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arden R.","family":"Barry","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences University of British Columbia Vancouver, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"key\n\t\t\t\t2019041103303703300_b1-0740786","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Stone","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"suppl","key":"key\n\t\t\t\t2019041103303703300_b2-0740786","doi-asserted-by":"crossref","first-page":"69C","DOI":"10.1016\/j.amjcard.2005.12.013","article-title":"An assessment of statin safety by muscle experts","volume":"97","author":"Thompson","year":"2006","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t2019041103303703300_b3-0740786","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMoa061894","article-title":"High-dose atorvastatin after stroke or transient ischemic attack","volume":"355","author":"Amarenco","year":"2006","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041103303703300_b4-0740786","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041103303703300_b5-0740786","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1056\/NEJMoa1600176","article-title":"Cholesterol lowering in intermediate-risk persons without cardiovascular disease","volume":"374","author":"Yusuf","year":"2016","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041103303703300_b6-0740786","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2007.02.049","article-title":"The role of coenzyme Q10 in statin-associated myopathy: a systematic review","volume":"49","author":"Marcoff","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2019041103303703300_b7-0740786","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.phrs.2015.07.008","article-title":"Statin therapy and plasma coenzyme Q10 concentrations\u2014a systematic review and meta-analysis of placebo-controlled trials","volume":"99","author":"Banach","year":"2015","journal-title":"Pharm Res"},{"key":"key\n\t\t\t\t2019041103303703300_b8-0740786","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1080\/15376510802305047","article-title":"Decreased ubiquinone availability and impaired mitochondrial cytochrome oxidase activity associated with statin treatment","volume":"19","author":"Duncan","year":"2008","journal-title":"Toxicol Mech Methods"},{"key":"key\n\t\t\t\t2019041103303703300_b9-0740786","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clpt.2005.03.006","article-title":"High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial","volume":"78","author":"P\u00e4iv\u00e4","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"key\n\t\t\t\t2019041103303703300_b10-0740786","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0002-9149(97)89180-1","article-title":"The effect of simvastatin treatment on natural antioxidants in low-density lipoproteins and high-energy phosphates and ubiquinone in skeletal muscle","volume":"77","author":"Laaksonen","year":"1996","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t2019041103303703300_b11-0740786","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1001\/archneur.62.11.1709","article-title":"Muscle coenzyme Q10 level in statin-related myopathy","volume":"62","author":"Lamperti","year":"2005","journal-title":"Arch Neurol"},{"key":"key\n\t\t\t\t2019041103303703300_b12-0740786","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.bcp.2009.12.007","article-title":"Effect of simvastatin on cholesterol metabolism in C2C12 myotubes and HepG2 cells, and consequences for statin-induced myopathy","volume":"79","author":"Mullen","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"key\n\t\t\t\t2019041103303703300_b13-0740786","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2217\/clp.09.83","article-title":"Survey of muscle characteristics after statin-induced rhabdomyolysis","volume":"5","author":"Phillips","year":"2010","journal-title":"Future Lipidol"},{"key":"key\n\t\t\t\t2019041103303703300_b14-0740786","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.trsl.2015.01.007","article-title":"Evidence for metabolic abberations in asymptomatic persons with type 2 diabetes after initiation of simvastatin therapy","volume":"166","author":"Suneja","year":"2015","journal-title":"Transl Res"},{"key":"key\n\t\t\t\t2019041103303703300_b15-0740786","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2013.04.009","article-title":"Ubiquinol rescues simvastatin-suppression of mitochondrial content, function and metabolism: implications for statin-induced rhabdomyolysis","volume":"711","author":"Vaughan","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"key\n\t\t\t\t2019041103303703300_b16-0740786","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.amjcard.2007.06.030","article-title":"Effect of coenzyme Q10 supplementation on simvastatin-induced myalgia","volume":"100","author":"Young","year":"2007","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t2019041103303703300_b17-0740786","doi-asserted-by":"crossref","first-page":"e182","DOI":"10.1016\/j.atherosclerosis.2007.06.010","article-title":"Effects of CoQ10 supplementation on plasma lipoprotein lipid, CoQ10 and liver and muscle enzyme levels in hypercholesterolemic patients treated with atorvastatin: a randomized, double-blind study","volume":"195","author":"Mabuchi","year":"2007","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t2019041103303703300_b18-0740786","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.atherosclerosis.2014.12.016","article-title":"A randomized trial of coenzyme Q10 in patients with confirmed statin myopathy","volume":"238","author":"Taylor","year":"2015","journal-title":"Atherosclerosis"},{"issue":"suppl 2","key":"key\n\t\t\t\t2019041103303703300_b19-0740786","doi-asserted-by":"crossref","first-page":"S498","DOI":"10.4103\/2230-8210.104144","article-title":"Oral use of \u201clow and slow\u201d rosuvastatin with co-enzyme Q10 in patients with statin-induced myalgia: retrospective case review","volume":"16","author":"Vidyarthi","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041103303703300_b20-0740786","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/biof.5520250116","article-title":"Treatment of statin adverse effects with supplemental coenzyme Q10 and statin drug discontinuation","volume":"25","author":"Langsjoen","year":"2005","journal-title":"Biofactors"},{"key":"key\n\t\t\t\t2019041103303703300_b21-0740786","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.amjcard.2006.12.063","article-title":"Effect of coenzyme Q10 on myopathic symptoms in patients treated with statins","volume":"99","author":"Caso","year":"2007","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t2019041103303703300_b22-0740786","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.amjcard.2012.04.026","article-title":"Effect of coenzyme Q10 supplementation on statin-induced myalgias","volume":"110","author":"Bookstaver","year":"2012","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t2019041103303703300_b23-0740786","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3109\/14017431.2012.756119","article-title":"No effect on combined coenzyme Q10 and selenium supplementation on atorvastatin-induced myopathy","volume":"47","author":"Bogsrud","year":"2013","journal-title":"Scand Cardiovasc J"},{"key":"key\n\t\t\t\t2019041103303703300_b24-0740786","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1139\/cjpp-2012-0118","article-title":"Coenzyme Q10 and selenium in statin-associated myopathy treatment","volume":"91","author":"Fedacko","year":"2013","journal-title":"Can J Physiol Pharmacol"},{"key":"key\n\t\t\t\t2019041103303703300_b25-0740786","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.12659\/MSM.890777","article-title":"Coenzyme Q10 supplementation decreases statin-related mild-to-moderate muscle symptoms: a randomized clinical study","volume":"20","author":"Skarlovnik","year":"2014","journal-title":"Med Sci Monit"},{"key":"key\n\t\t\t\t2019041103303703300_b26-0740786","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.mayocp.2014.08.021","article-title":"Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trials","volume":"90","author":"Banach","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"key\n\t\t\t\t2019041103303703300_b27-0740786","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/74\/11\/786\/28336065\/ajhp0786.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T21:33:20Z","timestamp":1659044000000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/74\/11\/786\/5102526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,1]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,6,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp160714","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,6,1]]},"published":{"date-parts":[[2017,6,1]]}}}